Allogenic Blood Transfusion During Elective Open Abdominal Aortic Surgery
1 other identifier
observational
426
0 countries
N/A
Brief Summary
Open surgery on the abdominal aorta is a high risk procedure associated with an intravascular volume blood loss and thereby, with high requirement for blood and blood product transfusion. The aim of this study was to establish the rate for allogenic blood transfusion (ABT) during elective open abdominal aortic surgery and find parameters associated with ABT requirements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2018
CompletedFirst Submitted
Initial submission to the registry
March 20, 2019
CompletedFirst Posted
Study publicly available on registry
March 27, 2019
CompletedMarch 29, 2019
March 1, 2019
6 years
March 20, 2019
March 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall ABT requirement
Overall ABT requirement (in %) during elective abdominal aortic surgery with the use of ICS for intraoperative blood salvage and autologous transfusion.
Retrospective analysis, 6-year period
Secondary Outcomes (12)
Age as the predictor of higher ABT requirement
Retrospective analysis, 6-year period
Gender as the predictors of higher ABT requirement
Retrospective analysis, 6-year period
Body mass index (BMI) as the predictors of higher ABT requirement
Retrospective analysis, 6-year period
Body surface area (BSA) as the predictors of higher ABT requirement
Retrospective analysis, 6-year period
Total blood volume as the possible predictors of higher ABT requirement
Retrospective analysis, 6-year period
- +7 more secondary outcomes
Study Arms (2)
Transfused group (TR)
Group received allogenic blood transfusion (ABT) alongside with autologous blood from intraoperative cell saver (ICS) during elective open abdominal aortic surgery.
Non-transfused (non-TR)
Group received only autologous blood from intraoperative cell saver (ICS) during elective open abdominal aortic surgery.
Interventions
During elective open aortic surgery, the autologous blood from ICS was processed and re-transfused in all patients. However, TR group additionally received ABT.
Eligibility Criteria
A retrospective cross-sectional study was conducted using an existing computerised medical records database at the Department of Anaesthesiology and Intensive Care at the Clinic for Cardiovascular Diseases Magdalena. This Clinic is a tertiary hospital in Croatia specialised in cardiac and vascular surgery. This study is a retrospective analysis of consecutive patients undergoing elective major vascular surgery who had been prospectively risk-stratified.
You may qualify if:
- Patients older than 18 years
- Elective open abdominal aortic surgery
- Abdominal aortic aneurysm repair
- Abdominal aortic bypass grafting for occlusive aortoiliac disease
You may not qualify if:
- Patients younger than 18 years
- Patients undergoing cardiac surgery
- Patients with ruptured abdominal aneurysms
- Patients undergoing endovascular aortic repair
- Patients submitted to other types of vascular surgery (i.e., carotid endarterectomy or peripheral bypass surgery)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, Gelijns AC, Greco G. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg. 2010 Sep;52(3):539-48. doi: 10.1016/j.jvs.2010.05.090. Epub 2010 Jul 13.
PMID: 20630687BACKGROUNDAshworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth. 2010 Oct;105(4):401-16. doi: 10.1093/bja/aeq244. Epub 2010 Aug 28.
PMID: 20802228BACKGROUNDRoubinian NH, Murphy EL, Swain BE, Gardner MN, Liu V, Escobar GJ; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III); Northern California Kaiser Permanente DOR Systems Research Initiative. Predicting red blood cell transfusion in hospitalized patients: role of hemoglobin level, comorbidities, and illness severity. BMC Health Serv Res. 2014 May 10;14:213. doi: 10.1186/1472-6963-14-213.
PMID: 24884605BACKGROUNDBursi F, Barbieri A, Politi L, Di Girolamo A, Malagoli A, Grimaldi T, Rumolo A, Busani S, Girardis M, Jaffe AS, Modena MG. Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery. Eur J Vasc Endovasc Surg. 2009 Mar;37(3):311-8. doi: 10.1016/j.ejvs.2008.12.002. Epub 2008 Dec 25.
PMID: 19111480BACKGROUND
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 20, 2019
First Posted
March 27, 2019
Study Start
January 1, 2011
Primary Completion
December 31, 2016
Study Completion
October 15, 2018
Last Updated
March 29, 2019
Record last verified: 2019-03